News / 14.12.2021
SSS becomes part of Optimapharm
Optimapharm, a leading European, mid-sized, full-service Clinical Research Organization that provides successful tailor-made clinical research solutions to Biotech, Pharma and Medical Device companies, is delighted to announce the acquisitions of SSS and Crown CRO, significantly strengthening its presence in key European markets in Western and Northern Europe and expanding its in-house capabilities, for the benefit of its biopharmaceutical clients worldwide.
read more
News / 31.05.2021
Post-Authorisation Safety Studies and their challenges
In the 2021 May issue of the renowned magazine International Clinical Trials, SSS reported about its experience in and knowledge of Phase IV trials. In this article, our authors focused on Post-Authorisation Safety Studies and their specific challenges when guiding and supporting sites in obtaining high quality data and in keeping timelines. SSS gained experience in this field from several studies and just recently implemented an IT solution for communication logs of the medical scientific expert team of the sponsor. By this means, SSS has facilitated the joint support from both, the CRO and the sponsor.
read more
Meet us at
General enquiries:
info@cro-sss.de
Tel: +49 89 800 650 0
General business opportunity and collaboration enquiries:
request.proposal@optimapharm.eu